CIK 0000072444
- Accelerated filer
- Smaller reporting company
Vaxart, Inc.
Sign in to watch- Ticker
- VXRT
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 591212264
- Phone
- +1 650-550-3500
- Business address
- 310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
- Former names
- Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-08-11 | Fox James Director | Grant or award | +2,500 | $2.49 | $6K | 2,500 |
| 2015-06-10 | Fox James Director | Purchase | +70,000 | $2.03 | $142K | 100,614 |
| 2015-06-09 | Fox James Director | Purchase | +70,000 | $1.99 | $139K | 100,614 |
| 2015-05-12 | Fox James Director | Grant or award | +7,500 | $2.20 | $17K | 7,500 |
| 2014-05-15 | Fox James Director | Grant or award | +7,500 | $2.85 | $21K | 7,500 |
| 2013-05-01 | Fox James Director | Grant or award | +8,700 | 8,700 | ||
| 2013-05-01 | Fox James Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 |
Page 1 of 1 · 7 trades